Structural & Congenital Heart Disease

Abbott acquires another TMVR device through purchase of Cephea
Abbott plans to acquire Cephea Valve Technologies, a company developing a transcatheter mitral…
Florida college launches country’s 1st open heart surgery program for dogs
The University of Florida College of Veterinary Medicine has partnered with veterinary cardiologist…
Pea-sized PDA occluder approved for premature babies in US
The FDA has approved the Amplatzer Piccolo Occluder as a minimally invasive treatment option for…
Study: Continued anticoagulation OK during TAVR for AFib patients
Patients with atrial fibrillation can safely continue oral anticoagulation (OAC) while undergoing…
Surgery tops drug therapy in boosting CHD patients’ quality of life
Adults with congenital heart disease (CHD) report better health-related quality of life (HRQoL)…
Surgical strategies, genetics affect tetralogy of Fallot survival
Almost 95 percent of patients survived 25 years after discharge for surgical repair of tetralogy of…
How climbing TAVR wait times affect patient outcomes
Developing an effective triage process for patients on the transcatheter aortic valve replacement (…
Industry group releases new guidelines for CT use in TAVR procedures
The Society of Cardiovascular Computed Tomography (SCCT) released updated guidelines for using CT…
TAVR system designed to treat aortic regurgitation used in 1st US patient
The first United States patient has been treated with the J-Valve TF system designed to address one…
The Way to Women’s Heart Health
Ramping up the battle against cardiovascular disease in women represents a golden opportunity to…
After COAPT: Getting MitraClip Right in the Real World
Will operators be able to replicate COAPT’s restraint & its outcomes?
More execs out at Johns Hopkins All Children's Hospital
Three more executives resigned from Johns Hopkins All Children’s Hospital in St. Petersburg,…
Design by Adaptivethemes.com